Charles A. Naggar’s practice focuses on intellectual property and patent litigation primarily involving pharmaceuticals, biotechnology, and medical device patent infringement matters, including Hatch-Waxman litigation.  His life sciences experience includes cases involving diabetes, cancer, fibromyalgia, cardiovascular disease, and vaccines.  Charles also represents technology companies in patent litigation involving computers and mobile devices, where he has experience litigating cases involving design patents, computer software, and cell phone technology.

Charles has experience in all aspects of patent litigation, including pre-filing investigation and strategy, fact and expert discovery, depositions, negotiations, claim construction, motion practice, settlement agreements, licensing, trials and appeals.  Additionally, he has experience with district court, International Trade Commission (ITC), Patent Trial and Appeal Board (PTAB), and appellate proceedings.

Before joining Kasowitz, Charles worked as a chemical engineer at a number of laboratories, including Joule Unlimited, Abbott Laboratories and Procter & Gamble.  His work involved pharmaceutical development, biofuel purification, biotechnology, and chemical technologies.

Charles’ pro bono activities include volunteering at family court and helping protect intellectual property rights of a non-profit organization devoted to supporting healthy eating and cooking habits for children.

Charles is recognized in The Best Lawyers in America’s “Ones to Watch” list in the Intellectual Property Law category.

Charles holds a Bachelor of Science degree in chemical engineering.

Charles is fluent in Hebrew.